Dazukibart is under clinical development by Pfizer and currently in Phase II for Systemic Lupus Erythematosus. According to GlobalData, Phase II drugs for Systemic Lupus Erythematosus have a 39% phase ...
KIPN will host national and international conferences to unite pain researchers at all career stages. These conferences will bring together clinicians and basic researchers to enhance the ...
Our editors also may be in touch with follow-up questions. Cannabidiol (CBD) may offer numerous health benefits, including pain relief and anxiety relief, without the intoxicatingly psychoactive ...
Together the two fires have charred 152 sq km – an area larger than Paris or nearly three times the size of Manhattan. A series of smaller fires in the Southern California region have been ...